Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...

Unlike Type 1 diabetes, patients with Type 5 do not show the usual antibodies. “Also, about 50% of them could be managed with tablets, not insulin. This is important as Type 5 is mostly seen in areas ...

A record entirely from the South, in a sector that has always been a thorn in the side. At the University Hospital of Palermo ...

The cause of type 1 diabetes remains unknown and is a central focus of Boston College Assistant Professor of Biology Emrah Altindis and others in his field hoping to find new ways to help 1.6 million ...

Type 1.5 diabetes is commonly known as LADA ... One test that may be different is an antibody test. Healthcare professionals use this test to determine if you have an autoimmune reaction in ...

Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

“including those with history of an autoimmune condition or a family history of type 1 diabetes. There are also screening programs that can screen anyone for these antibodies regardless of their risk.

A world-first human trial of a drug designed to treat the underlying cause of type 1 diabetes has begun in Australia. Five patients with the condition have already been dosed as part of the trial ...

Type 5 Diabetes, has now come under the spotlight after official recognition by the International Diabetes Federation. This ...